Showing results (191-200 of 215) with videos related to
Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2017
Gray and White Matter Abnormalities in Treated Human Immunodeficiency Virus Disease and Their Relationship to Cognitive FunctionJonathan Underwood, James H Cole, Matthan Caan, et al.HIV Medicine|August 8, 2022
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA studyMyroslava Nikolaichuk, Amanda Mocroft, Gilles Wandeler, et al.The Journal of Infectious Diseases|October 26, 2017
Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid BiomarkersRosan A van Zoest, Jonathan Underwood, Davide De Francesco, et al.Plos One|March 30, 2018
The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristicsDavide De Francesco, Ferdinand W Wit, James H Cole, et al.Nature Reviews. Neurology|June 13, 2023
Cognitive impairment in people living with HIV: consensus recommendations for a new approachSam Nightingale, Beau Ances, Paola Cinque, et al.Journal of Virus Eradication|October 27, 2016
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USAJeymohan Joseph, Paola Cinque, Deborah Colosi, et al.AIDS Research and Human Retroviruses|November 2, 2022
Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging WorkshopXiaoying Yu, Judith D Lobo, Erin Sundermann, et al.HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.Pageof 22